All Wise Information.Com
Clear Information To Make You Wiser.
LEV's Lighting Information
ViroPharma's Growing Pains (Forbes) The biotech firm sunk after picking up the little-known Lev Pharmaceuticals. ViroPharma buying N.Y. drug-maker (Philly.com) ViroPharma Inc., Exton, says it will pay $442.9 million for anti-inflammatory drug developer Lev Pharmaceuticals Inc., New York, plus up to $174.6 million in bonus payments if Lev's Cinryze drug for treating hereditary angioedema (HAE) meets regulatory and sales goals. Top-Rated Stocks the Leaders Loathe (The Motley Fool) These top-rated stocks have been marked down by top-rated investors. Are they right to have a sour puss on? ViroPharma Adopts An Orphan Drug (Forbes) The biotech company's shares sink after it agrees to buy little-known Lev Pharmaceuticals. Movers roundup: Bellus Health, ViroPharma (AP via Yahoo! Finance) Shares of Bellus Health Inc. gained Wednesday after the Canadian biotechnology company said it will buy privately-held Innodia Inc. for about $1.3 million, gaining development programs for diabetes and obesity therapies. ARTS + FEATURES (St. Petersburg Times) History or invention, David Benioff?s Russia-set ?City of Thieves? shows that a master storyteller has arrived. Ahead of the Bell: ViroPharma upgraded (AP via Yahoo! Finance) A Thomas Weisel analyst upgraded shares of ViroPharma Inc. Wednesday, saying the company has gained a key drug candidate in its buyout of Lev Pharmaceuticals. ViroPharma to acquire Lev Pharmaceuticals (PharmaBiz) ViroPharma Incorporated and Lev Pharmaceuticals, Inc. announced that the companies have signed a definitive merger agreement under which ViroPharma will acquire Lev, a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases, for $442.9 million of upfront consideration, or $2.75 per Lev share, comprised of $2.25 per share ... Movers roundup: USANA Health Sciences, ViroPharma (AP via Yahoo! Finance) Shares of USANA Health Sciences Inc. tumbled Wednesday after a firm controlled by the company's chief executive ended its bid to buy the nutritional supplement and skin care products maker. ViroPharma rises, then pares gains after Lev deal (AP via Yahoo! Finance) ViroPharma Inc. shares wavered Wednesday as Wall Street took a second look at the company's buyout of Lev Pharmaceuticals and Lev's drug candidate Cinryze. |
|
All Shopping Information All Business Information All Automotives Information All Banking Information All Electronics Information All Financial Information All Entertainment Information All Health Information All Home Improvement Information All Home Theaters Information All Insurance Information All Legal Services Information All Money Information All Internet Information All Property Information All Vacations information All Travel Information All Economy Information All Investment information All Technology Information |
Wise Information Categories
All information and links are auto loaded daily to give you updated wise information
All Wise Information Wise Information News Archives Information Posts Search Partner Directories Contact Us Privacy Statement Site Map
All Wise Information.Com
© Copyright All Wise Information®